Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of a novel continuous glucose monitoring system designed to give users unprecedented insight into their personal metabolic activity. The company's sensors are highly accurate, factory calibrated, and very low cost to manufacture, allowing sensors to detect glucose electrochemically via a proprietary new sensing technology, enabling users to monitor their diabetes and receive user friendly reports to their phones.
You’re viewing a free company profile from the PitchBook Platform. To explore Glucovation’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Corporate | 10-Apr-2017 | $3.1M | 00.000 | Completed | Product In Beta Test | |
4. Early Stage VC | 10-Apr-2017 | 000 | 00.000 | 0000 | Completed | Product In Beta Test |
3. Corporate | 10-Jul-2016 | 00.00 | 00.000 | Completed | Startup | |
2. Early Stage VC (Series A) | 01-Nov-2015 | $2M | $2.65M | 0000 | Completed | Startup |
1. Seed Round | 10-Jun-2014 | $650K | $650K | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Terumo | Corporation | Minority | 000 0000 | 000000 0 |
2 Former Executives
You’re viewing 3 of 5 executives. Get the full list »Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
Jeff Suri Ph.D | Glucovation | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 | |
Ken San Vicente | Glucovation | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
Kyle Huynh | Glucovation | Co-Founder, Chief Operating Officer & Board Member | 000 0000 |